The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety

Dudley, 2020, The state of vaccine safety science: systematic reviews of the evidence, Lancet Infect Dis, 10.1016/S1473-3099(20)30130-4 Rid, 2020, The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials, JAMA https://pubmed.ncbi.nlm.nih.gov/12456938/. https://pubmed.ncbi.nlm.nih.gov/14585633/. https://pubmed.ncbi.nlm.nih.gov/9326478/. COVID, CDC, and Response Team. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine—United States, December 14–23, 2020. Morbidity and Mortality Weekly Report 70.2, 2021: 46. Torjesen, Ingrid. Covid-19: Norway investigates 23 deaths in frail elderly patients after vaccination. 2021. Whitaker, 2009, The methodology of self-controlled case series studies, Stat Methods Med Res, 18, 7, 10.1177/0962280208092342 Dodd CN, Willame C, Sturkenboom M. Background rates of Adverse Events of Special Interest for monitoring COVID-19 vaccines EUPAS37273 http://www.encepp.eu/encepp/viewResource.htm?id=37274. https://www.globalvaccinedatanetwork.org. Remschmidt, 2015, Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a systematic review, BMC Infect Dis, 15, 1, 10.1186/s12879-015-1154-y Kuitunen, 2020, Effect of social distancing due to the COVID-19 pandemic on the incidence of viral respiratory tract infections in children in Finland during early 2020, Pediatr Infect Dis J, 39, e423, 10.1097/INF.0000000000002845 https://vac4eu.org/covid-19-vaccine-monitoring/. Lieu Tracy A, Kulldorff Martin, Davis Robert L, Lewis Edwin M, Weintraub Eric, Yih Katherine, et al., Vaccine Safety Datalink Rapid Cycle Analysis Team. Real-time vaccine safety surveillance for the early detection of adverse events. Medical Care 2007:S89–S95. Takii Toru, Satoshi Yasuda, Jun Takahashi, Kenta Ito, Nobuyuki Shiba, Kunio Shirato, et al., MIYAGI-AMI Study Investigators. Trends in acute myocardial infarction incidence and mortality over 30 years in Japan. Circulation J. 2010: 0911240524–0911240524. Yeh, 2010, Population trends in the incidence and outcomes of acute myocardial infarction, N Engl J Med, 362, 2155, 10.1056/NEJMoa0908610 Black, 2009, Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines, The Lancet, 374, 2115, 10.1016/S0140-6736(09)61877-8 Michelson, 2018, Trends in severe pediatric emergency conditions in a National Cohort, 2008 to 2014, Pediatr Emerg Care, 16, 16 Lin, 2008, Increasing anaphylaxis hospitalizations in the first 2 decades of life: New York State, 1990–2006, Ann Allergy Asthma Immunol, 101, 387, 10.1016/S1081-1206(10)60315-8 Yang, 2017, True rise in anaphylaxis incidence: Epidemiologic study based on a national health insurance database, Medicine, 96, e5750, 10.1097/MD.0000000000005750 Nemet, 2015, Considerations and complications after Bells’ palsy, J Clin Neurosci, 22, 1949, 10.1016/j.jocn.2015.04.030 Katusic, 1986, Incidence, clinical features and prognosis in Bells palsy, Rochester, Minnesota. 1968-1982, Ann Neurol, 20, 622, 10.1002/ana.410200511 https://www.cdc.gov/nchs/data/databriefs/db328_tables-508.pdf#3. http://www.indepth-network.org/Resource%20Kit/INDEPTH%20DSS%20Resource%20Kit/LinkedDocuments/INDEPTH%20Monograph%20I%20Ch1-7%20Introduction,%20Methods%20&%20Life%20Tables.pdf. Klein, 2010, Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies, Vaccine, 28, 1062, 10.1016/j.vaccine.2009.10.115 Jeffery, 1993, Transverse myelitis. Retrospective analysis of 33 cases, with diff erentiation of casesassociated with multiple sclerosis and parainfectious events, Arch Neurol, 50, 532, 10.1001/archneur.1993.00540050074019 Beghi, 1985, Guillain-Barré syndrome. Clinicoepidemiologic features and effect of influenza vaccine, Arch Neurol., 42, 1053, 10.1001/archneur.1985.04060100035016 Huang, 2015, A 15 year nationwde epidemiological analysis of Guillain-Barré Syndrome in Taiwan, Neuroepidemology, 44 Williams C, Dodd C, Sturkenboom M. et al. Incidence rates of autoimmune diseases in european healthcare databases: A contribution of the ADVANCE Project. Drug Safety online January 19, 2021. https://doi.org/10.1007/s40264-020-01031-1. Alonso, 2007, Incidence of multiple sclerosis in the United Kingdom, J Neurol, 254, 1736, 10.1007/s00415-007-0602-z